Search Results - "Gray, Jennifer N."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    KidneyCare Guided Immuno-Optimization in Renal Allografts: The KIRA Protocol by Gray, Jennifer N, Wolf-Doty, Theresa, Sulejmani, Nimisha, Gaber, Osama, Axelrod, David, Abdalla, Basmah, Danovitch, Gabriel

    Published in Methods and protocols (30-09-2020)
    “…Immunosuppressant agents are essential in every transplant recipient's care yet walking the fine line of over- or under-immunosuppression is a constant…”
    Get full text
    Journal Article
  2. 2

    Relative Change in Donor-Derived Cell-free DNA is Superior to Absolute Values for Diagnosis of Acute Lung Allograft Dysfunction by Trindade, Anil J., Chapin, Kaitlyn C., Gray, Jennifer N., Furuya, Yuka, Mullican, Amy, Hoy, Haley, Demarest, Caitlin T., Robbins, Ivan M., Bacchetta, Matthew, Erasmus, David B., Shaver, Ciara M.

    Published in Transplantation direct (01-06-2023)
    “…Donor-derived cell-free DNA (dd-cfDNA%) is a biomarker of early acute lung allograft dysfunction (ALAD), with a value of ≥1.0% indicating injury. Whether…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Characteristics of U.S. waterpipe users: A preliminary report by Ward, Kenneth D., Eissenberg, Thomas, Gray, Jennifer N., Srinivas, Vidya, Wilson, Nancy, Maziak, Wasim

    Published in Nicotine & tobacco research (01-12-2007)
    “…Waterpipe smoking, a traditional method of tobacco use, has experienced a resurgence in the Middle East and Indian subcontinent in recent years. Despite…”
    Get full text
    Journal Article
  5. 5

    Potential reduced exposure products (PREPs) for smokeless tobacco users: Clinical evaluation methodology by Gray, Jennifer N., Breland, Alison B., Weaver, Michael, Eissenberg, Thomas

    Published in Nicotine & tobacco research (01-09-2008)
    “…Several potential reduced exposure products (PREPs) for smokeless tobacco (SLT) users are marketed in the United States, though their effects are largely…”
    Get full text
    Journal Article